Advertisement
Advertisement
U.S. markets open in 7 hours 28 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
225.49-0.83 (-0.37%)
At close: 04:00PM EDT
225.49 0.00 (0.00%)
After hours: 04:47PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close226.32
Open226.84
Bid225.42 x 1200
Ask0.00 x 800
Day's Range223.57 - 227.59
52 Week Range203.37 - 460.21
Volume352,469
Avg. Volume549,593
Market Cap11.456B
Beta (5Y Monthly)1.27
PE Ratio (TTM)27.48
EPS (TTM)8.20
Earnings DateAug 02, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est327.64
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
7% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CRL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Charles River Laboratories Inte
    Analyst Report: Charles River Laboratories International, Inc.Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
    Rating
    Fair Value
    Economic Moat
    19 days agoMorningstar
View more
Advertisement
Advertisement